The present invention relates to selective NK-1 receptor antagonists of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of disorders associated with an excess of tachykinins.
-
Page 29
(2010/02/10)
Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 1. Structure-activity relationships.
-
Fuller,Molloy,Day,Roush,Marsh
p. 101 - 106
(2007/10/06)
More Articles about upstream products of 731827-07-9